International Journal of Cardiology · 2016 · 22 citations · 26 references
PharmacyCardiologyPharmacoeconomicsCost-effectiveness AnalysisCost-utility AnalysisPharmacoeconomic ModelingAnticoagulant TherapyAnticoagulation TherapyAntithrombotic TherapyAtrial FibrillationCost-effectiveness ModelingPharmacoepidemiologyAnticoagulation In Older AdultsBleeding Risk ReductionComparative Cost-effectivenessCost-effectivenessGeriatric Anticoagulation
26
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina et al. · EP Europace · 2012 · 3.8K citations · Full text